Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
about
Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidenceThe stats are in: an update on statin use in COPDAirway hydration and COPDAcquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.Biologic phenotyping of the human small airway epithelial response to cigarette smoking.Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cellsCigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.Smoking-mediated up-regulation of GAD67 expression in the human airway epithelium.Regulation of particulate matter-induced mucin secretion by transient receptor potential vanilloid 1 receptors.Asthma, airway biology, and nasal disorders in AJRCCM 2001.The standardized herbal formula, PM014, ameliorated cigarette smoke-induced lung inflammation in a murine model of chronic obstructive pulmonary disease.Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface.Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium.Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia.Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease.Phenotypic and physiologic variability in nasal epithelium cultured from smokers and non-smokers exposed to secondhand tobacco smoke.Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury.CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity.Drugs in clinical development for chronic obstructive pulmonary disease.Airway mucus: From production to secretion.Increased human Ca²⁺-activated Cl⁻ channel 1 expression and mucus overproduction in airway epithelia of smokers and chronic obstructive pulmonary disease patients.Roles of apoptosis in airway epithelia.Bronchial epithelial spheroids: an alternative culture model to investigate epithelium inflammation-mediated COPD.Treatment of airway mucus hypersecretion.A2B adenosine receptors regulate the mucus clearance component of the lung's innate defense system.Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease.Increased nasal epithelial ciliary beat frequency associated with lifestyle tobacco smoke exposureChronic rhinosinusitis and risk of lung cancer in the Singapore Chinese Health Study.Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease.Standardized Herbal Formula PM014 Inhibits Radiation-Induced Pulmonary Inflammation in Mice.A causal model of chronic obstructive pulmonary disease (COPD) risk.Phenotyping the heterogeneity of chronic obstructive pulmonary disease.Transient receptor potential vanilloid 1 receptors mediate acid-induced mucin secretion via Ca2+ influx in human airway epithelial cells.Evaluation of inhaled carbon monoxide as an anti-inflammatory therapy in a nonhuman primate model of lung inflammation.Tobacco smoke control of mucin production in lung cells requires oxygen radicals AP-1 and JNK.LPS-induced neutrophilic inflammation and Bcl-2 expression in metaplastic mucous cells.Upregulation of pirin expression by chronic cigarette smoking is associated with bronchial epithelial cell apoptosis.Studies of gamma-glutamyl transferase in alpha-1 antitrypsin deficiency.
P2860
Q26206514-66969594-B9F4-4978-B167-3508CBBECF93Q26778906-1B627A16-30B7-437D-950F-94992F1168D5Q28082617-46FFEEA6-FC13-4039-A849-27251D5B6B8BQ33586131-92F606AC-B8DE-4F35-BDB7-DAB1BB2C92EDQ33898627-6129FDF2-25FC-474A-BB0C-86FA85D797FBQ33987902-872D37FE-D94C-4047-8C71-BEA00DF21D36Q34227089-20326A99-ED1B-4984-BC86-C412AEE394A3Q34331195-B9E336EB-20B3-49F1-91D3-EF893E8A0E45Q34335404-792F12E3-326A-43AF-88F6-7EBCA8DB950CQ34350607-A154DBA1-D995-4444-A8FC-87827F936DD7Q34550135-47329A8F-6B46-4DE0-A775-6B490FF9DA79Q34980255-43485F8A-3CFD-4602-BA5C-4B30599EA6AEQ35035573-EB659E65-5D5C-4D4D-87F3-65AAF87C0A4EQ35083454-AD179513-A7AC-48A2-9E42-3611766D8336Q35107688-E8C1C085-1343-4348-8106-A6092B33D984Q35152773-0F2995DB-F43E-4904-9F2F-D11C50903A34Q35350620-4D33E2FD-AD82-424A-9716-28F10B6081DEQ35620083-EDFD2DA7-2D70-4E1B-9102-0797115BF0AFQ35963185-1D97F74F-EEDD-447F-86F4-0586C21C67BEQ36064621-8B6B99B4-3936-409C-9D21-FF4895367E70Q36369409-8ABC2B3F-46CB-4E92-9AE1-4F4019E28DC5Q36373267-30144FC0-6404-4C25-B594-AD9C87A8C0F8Q36378783-E9F1047C-2E79-40C1-AA7D-8B6D020A0F9AQ36407068-D62A4820-E453-4C1F-9E7A-9B0E1016EF08Q36438219-29A294DC-DB7E-4A45-8F13-735B84CE885FQ36890036-9FBE7A22-8CDB-4C53-8487-DFE701715B83Q37082562-75118249-ED1E-4E87-BA96-0656F3A9903CQ37291975-BA7D22F4-CD28-45B8-925F-8BDAE29D6A99Q37309286-1257CA2C-B5DC-4D6E-A562-8F563F0F19F7Q37332621-8424E650-3E59-4CC9-8E4D-33F892FBCB27Q37368041-7CF58FBA-F134-409C-BE68-C547C5060B9EQ37712927-A50C5ABB-CF78-4410-9AF0-B0389B14F0FFQ37789415-CA825329-EDF2-4C5A-81B5-D0C5F8EE72D2Q38063326-4E2AA80F-D7BD-4C6C-BB19-60A8400A0376Q39352196-2C348411-8F54-4E90-BFBC-217C48022287Q39845255-75C4751E-461B-404B-8AEE-CBE9DA39CF89Q40533722-E58381C2-4F0A-4516-86C9-A695D408A9B7Q40654047-FD0A7267-AAE6-4E0F-89C4-250381B30DD2Q41853226-5181F1E0-A59E-4036-8013-BA26FD30F0BFQ43096627-510C6B9C-5CCF-47E8-A465-3011E677E285
P2860
Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Remodeling in response to infe ...... obstructive pulmonary disease.
@ast
Remodeling in response to infe ...... obstructive pulmonary disease.
@en
Remodeling in response to infe ...... obstructive pulmonary disease.
@nl
type
label
Remodeling in response to infe ...... obstructive pulmonary disease.
@ast
Remodeling in response to infe ...... obstructive pulmonary disease.
@en
Remodeling in response to infe ...... obstructive pulmonary disease.
@nl
prefLabel
Remodeling in response to infe ...... obstructive pulmonary disease.
@ast
Remodeling in response to infe ...... obstructive pulmonary disease.
@en
Remodeling in response to infe ...... obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Remodeling in response to infe ...... obstructive pulmonary disease.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.164.SUPPLEMENT_2.2106067
P407
P433
P577
2001-11-01T00:00:00Z